Aisha Lindman

AISHA LINDMAN IS THE FOUNDER AND MANAGING PARTNER OF KORALIS CORPORATE, AN INVESTOR RELATIONS AGENCY SERVING TECHNOLOGY COMPANIES WITH A HIGH DEMAND FOR RESEARCH AND INNOVATION. KORALIS CORPORATE OFFERS INTEGRATED STRATEGIC IR SERVICES AND ASSISTS CLIENTS WITH A STRUCTURED APPROACH TO IPO'S AND OTHER CAPITAL MARKET TRANSACTIONS.

AISHA HAS OVER 20 YEARS OF PROFESSIONAL EXPERIENCE, WITH 15 YEARS FOCUSED ON INVESTOR RELATIONS, CORPORATE, AND LEGAL AFFAIRS. SHE HAS SUCCESSFULLY PARTNERED WITH CEOS AND SENIOR EXECUTIVES ON MULTIPLE FINANCING TRANSACTIONS, RAISING OVER USD 600 MILLION.

PRIOR TO STARTING HER OWN CONSULTING BUSINESS, SHE WAS THE DIRECTOR OF CORPORATE AFFAIRS AT NORTHSEA THERAPEUTICS (NST) WHERE SHE WAS RESPONSIBLE FOR THE DEVELOPMENT AND IMPLEMENTION OF PRE- AND POST-IPO INVESTOR RELATIONS, ALONGSIDE OVERSEEING CORPORATE GOVERNANCE AND COMPLIANCE MATTERS. BEFORE NST, SHE SERVED AS DIRECTOR OF CORPORATE & LEGAL AFFAIRS AT G7 THERAPEUTICS AG, PLAYING A KEY ROLE IN ITS ACQUISITION BY HEPTARES THERAPEUTICS FOR 12M CHF.

FROM 2009 TO 2016, AISHA WAS THE HEAD OF INVESTOR RELATIONS AND ACTING CORPORATE SECRETARY AT THE NASDAQ-LISTED COMPANY UNIQURE N.V. DURING HER TIME AT UNIQURE SHE HAS LED THE IMPLEMENTATION OF MULTIPLE INVESTOR RELATIONS, LEGAL, COMPLIANCE AND CORPORATE GOVERNANCE PROGRAMS. SHE SUPPORTED THE PROCESS OF PREPARATION OF THE NASDAQ LISTING (92M USD), INCLUDING THE MARKETING DOCUMENTATION (F1) AND SELECTION OF THE BANKING SYNDICATE AND WAS PART OF THE CORE TEAM IN A CRUCIAL COMPANY TRANSITION INVOLVING A DELISTING FROM THE EURONEXT STOCK EXCHANGE, A SUBSEQUENT LISTING ON NASDAQ, M&A AND OTHER MAJOR FINANCIAL TRANSACTIONS.

AISHA HOLDS A BACHELOR OF LAW FROM AMSTERDAM UNIVERSITY AND AN MBA FROM THE ROTTERDAM SCHOOL OF MANAGEMENT, ERASMUS UNIVERSITY. SHE IS FLUENT IN ENGLISH AND DUTCH AND CONVERSATIONAL IN SWEDISH, FRENCH, AND ARABIC.